Czechia, July 21 -- Czechia based Bristol-Myers Squibb spol. s r.o. has secured contract from Institut klinicke a experimentalni mediciny for Cardiac therapy medicinal products - Kardiaka 12 - Mavakamten . The value of the contract is worth 65564002 CZK .
Published by HT Digital Content Services with permission from Pivotal Sources....